EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Comparing the efficacy of plasma exeresis and cryotherapy for the treatment of seborrheic keratosis: A randomized controlled trial

Maryam Noorbakhsh, Yasamin Kalantari iD, Erfan Ghasemi, Babak Shokri, Hamidreza Mahmoudi iD, Maryam Daneshpazhooh iD, Ifa Etesami iD, Mohammadreza Khani

Skin Research and Technology · 2023

DOI: 10.1111/srt.13429 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Skin Research and Technology, 2023. Verfasst von Maryam Noorbakhsh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Keratosis, Seborrheic, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Seborrheic keratoses (SK) is a benign epithelial skin tumor and plasma exeresis is a new technique.

Aims

To compare the efficacy and safety of plasma exeresis and cryotherapy for treating SK.

Methods

This study is a randomized controlled trial (RCT). One side of each patient was randomly treated with plasma exeresis (peak‐to‐peak voltage of 3.44 kV and a frequency of 62.5 kHz) and the other side with cryotherapy.

Results

Thirty‐five males were enrolled. At week 3, 37.1 % (N = 13) of lesions treated by plasma exeresis were clear, which was higher than those treated by cryotherapy 17.1% (N = 6). However, this difference was not significant ( p ‐value: 0.06). At week 6, 16 (57.1 %) out of 28 remaining lesions, treated by plasma exeresis were clear, which was significantly higher ( p ‐value: 0.005) than those completely cleared by cryotherapy in 6 out of 29 remaining lesions (20.7%). The mean physician assessment scale score was significantly reduced in both groups in the second follow‐up (plasma group first follow‐up 0.91 ± 0.89 vs. second follow‐up 0.5 ± 0.64 and p ‐value: 0.0031; cryo group first follow‐up 1.4 ± 0.84 vs. second follow‐up 1.1 ± 0.72 and p ‐value: 0.0002). Regarding side effects, no significant difference was seen ( p = 0.438). The most common complications in the plasma and cryotherapy groups were erythema (10/19, 52.63%) and hypo pigmentation (5/13, 38.46%).

Conclusions

Both cryotherapy and plasma exeresis are effective. We observed a significantly higher cleared lesions treated with plasma exeresis in 6 weeks and after two sessions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Keratosis, SeborrheicSkin NeoplasmsMaleHumansCryotherapyPigmentation

Stichwörter der Autor:innen

plasma exeresis seborrheic keratoses

Autor:innen und Institutionen

  • Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran.
  • Physics Department of Shahid Beheshti University, Tehran, Iran.

ORCID-Profile: Yasamin Kalantari, Hamidreza Mahmoudi, Maryam Daneshpazhooh, Ifa Etesami

Zitieren

APA

Noorbakhsh, M., Kalantari, Y., Ghasemi, E., Shokri, B., Mahmoudi, H., Daneshpazhooh, M., Etesami, I., & Khani, M. (2023). Comparing the efficacy of plasma exeresis and cryotherapy for the treatment of seborrheic keratosis: A randomized controlled trial. Skin Research and Technology. https://doi.org/10.1111/srt.13429

Vancouver

Noorbakhsh M, Kalantari Y, Ghasemi E, Shokri B, Mahmoudi H, Daneshpazhooh M, et al. Comparing the efficacy of plasma exeresis and cryotherapy for the treatment of seborrheic keratosis: A randomized controlled trial. Skin Research and Technology. 2023. doi:10.1111/srt.13429

BibTeX
@article{Noorbakhsh2023,
  author = {Noorbakhsh, Maryam and Kalantari, Yasamin and Ghasemi, Erfan and Shokri, Babak and Mahmoudi, Hamidreza and Daneshpazhooh, Maryam and Etesami, Ifa and Khani, Mohammadreza},
  title = {Comparing the efficacy of plasma exeresis and cryotherapy for the treatment of seborrheic keratosis: A randomized controlled trial},
  journal = {Skin Research and Technology},
  year = {2023},
  doi = {10.1111/srt.13429}
}
Kostenlos starten →